Imiquimod (AldaraTM Cream)

Imiquimod (AldaraTM Cream)

Bibliographic Details
Main Author:	H. W. Buck
Format:	Article
Language:	English
Published:	Hindawi Limited 1998-01-01
Series:	Infectious Diseases in Obstetrics and Gynecology
Online Access:	http://dx.doi.org/10.1155/S106474499800012X

Similar Items

The Systemic Response to Topical Aldara Treatment is Mediated Through Direct TLR7 Stimulation as Imiquimod Enters the Circulation
by: Louis Nerurkar, et al.
Published: (2017-11-01)

Therapeutic use of Aldara™ in chronic myeloid leukemia
by: Marleau Annette M, et al.
Published: (2007-01-01)

Imiquimod 5% Cream for Treatment of Actinic Keratosis of the Eyelid
by: Gamze Ozturk Karabulut, et al.
Published: (2017-05-01)

Topical treatment of actinic keratosis with imiquimod 5% cream
by: T.N.A. Garcez, et al.
Published: (2012-12-01)

Genital vitiligo following use of imiquimod 5% cream
by: Ruzhi Zhang, et al.
Published: (2011-01-01)

Treatment of cutaneous tumors with topical 5% imiquimod cream
by: Sabrina Sisto Alessi, et al.
Published: (2009-01-01)

Disseminated Superficial Actinic Porokeratosis on the Face Treated with Imiquimod 5% Cream
by: Hassan Riad, et al.
Published: (2013-10-01)

Erythroplasia of Queyrat treated with imiquimod 5% cream: The necessity of regimen guidelines
by: Maiko Yokoyama, et al.
Published: (2019-04-01)

Imiquimod 5% cream in topical treatment of facial basal cell carcinoma
by: Grubor Svetlana D., et al.
Published: (2015-01-01)

Penile Intraepithelial Neoplasia: Successful Treatment with Topical 5% Imiquimod Cream
by: Stojanović Slobodan, et al.
Published: (2012-12-01)

JNK1 Signaling Downstream of the EGFR Pathway Contributes to Aldara®-Induced Skin Inflammation
by: Aurore Le, et al.
Published: (2021-02-01)

Clinical case of basal cell carcinoma therapy using 5 % imiquimod cream
by: H. I. Makurina, et al.
Published: (2020-08-01)

Vitiligo-Like Depigmentation following Treatment with Imiquimod 5% Cream for Condylomata Acuminata
by: Maram Alatabani, et al.
Published: (2021-01-01)

Efficacy of imiquimod 5% cream for persistent human papillomavirus in genital intraepithelial neoplasm
by: Fang-Ping Chen
Published: (2013-12-01)

Elastosis Perforans Serpiginosa in a patient with Down syndrome treated with imiquimod 5% cream.
by: Pernille Axèl Gregersen, et al.
Published: (2010-10-01)

Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream
by: Raghavan Shalini, et al.
Published: (2007-01-01)

Pigmented basal cell carcinoma successfully treated with 5% imiquimod cream
by: Mehta Vandana, et al.
Published: (2008-01-01)

Visualization and Treatment of Subclinical Actinic Keratoses with Topical Imiquimod 5% Cream: An Observational Study
by: Daisy Kopera, et al.
Published: (2014-01-01)

Facial basal cell carcinoma treated with topical 5% imiquimod cream with dermoscopic evaluation
by: Archana Singal, et al.
Published: (2016-01-01)

Quick cytological diagnosis and rapid improvement with imiquimod cream in a case of orf infection
by: Murat Durdu
Published: (2016-03-01)

Therapeutic Efficacies of Artemisia capillaris Extract Cream Formulation in Imiquimod-Induced Psoriasis Models
by: Song Yi Lee, et al.
Published: (2018-01-01)

Clinical efficacy, safety and tolerance of the Kerawort (imiquimod) cream used for treatment of anogenital warts
by: M. R. Rakhmatulina, et al.
Published: (2017-08-01)

Effect of Adjuvant Imiquimod 5% Cream on Sustained Clearance of Anogenital Warts Following Laser Treatment
by: U. B. Hoyme, et al.
Published: (2001-01-01)

Effective Combination of Photodynamic Therapy and Imiquimod 5% Cream in the Treatment of Actinic Keratoses: Three Cases
by: Laura Held, et al.
Published: (2013-01-01)

Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area
by: Gamze Ozturk Karabulut, et al.
Published: (2017-01-01)

EFFICACY OF GENERIC DRUG WARTOCID® (IMIQUIMOD 5% CREAM FOR EXTERNAL USE) IN ANOGENITAL WARTS TREATMENT
by: V. S. Smirnova, et al.
Published: (2017-09-01)

Tratamento do papiloma vírus humano na infância com creme de imiquimode a 5% Treatment of human papillomavirus in childhood with imiquimod 5% cream
by: Hebert Roberto Clivati Brandt, et al.
Published: (2010-08-01)

Successful treatment of giant basal cell carcinoma with topical imiquimod 5% cream with long term follow-up
by: M Chun-Guang, et al.
Published: (2014-01-01)

Case of giant vulvar condyloma acuminata successfully treated with imiquimod 3.75% cream: A case report
by: Matthew Hum, et al.
Published: (2018-10-01)

Efficacy and safety of 5% imiquimod cream compared to 10% KOH solution for elimination of molluscum contagiosum lesions in adults
by: Marsha Bianti, et al.
Published: (2019-06-01)

Vulvar condylomatosis after sex reassignment surgery in a male-to-female transsexual: Complete response to imiquimod cream
by: Trinidad Labanca, et al.
Published: (2017-05-01)

Imiquimod 5% Cream for an Annular Plaque with Progressive Pain on the Right Distal Arm in the Cubital Fossa: Acquired Tufted Angioma
by: Wang J, et al.
Published: (2021-07-01)

A comparative study of 10% KOH solution and 5% imiquimod cream for the treatment of Molluscum contagiosum in the pediatric age group
by: Namitha Chathra, et al.
Published: (2015-01-01)

Melanoma "in situ" tratado con Imiquimod Melanoma in situ treated with Imiquimod
by: RE Achenbach, et al.
Published: (2012-01-01)

The SINS trial: A randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma
by: Armstrong Sarah J, et al.
Published: (2010-04-01)

Erythroplasia of Queyrat Treated with 5% Imiquimod Cream — Case Report Emphasizing the Role of Human Papilloma Virus Testing in a Clinical Setting
by: Chiriac Anca, et al.
Published: (2017-03-01)

Imiquimod 3.75% Cream Applied Daily to Treat Anogenital Warts: Combined Results from Women in Two Randomized, Placebo-Controlled Studies
by: David A. Baker, et al.
Published: (2011-01-01)

Imiquimod 5% cream in the treatment of superficial and nodular basal cell carcinomas: study of 10 cases Tratamento tópico do carcinoma basocelular superficial e nodular pelo imiquimod creme a 5%: observação de 10 casos
by: Cyro Festa Neto
Published: (2002-12-01)

Chemical Stability of Hydrocortisone in Topical Preparation in Proprietary VersaProTM Cream Base
by: Arindam Basu Sarkar, et al.
Published: (2011-01-01)

The role of imiquimod in the megakaryocyte differentiation
by: Tzu-Yu Chien, et al.
Published: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vhbe3b9s78r60lmrt9bj6j781f